热门资讯> 正文

Absci大举收购礼来、私募股权投资

2026-06-24 19:25

Absci (ABSI) is up ~20% in premarket trading Monday after announcing $100M in financing from Eli Lilly (LLY) as well as several private equity firms.
The biopharma has priced an underwritten offering of 13,495,277 shares at $7.41 per share.
Adage, BVF Partners, Columbia Threadneedle, Invus, and Redmile are among the private equity investors.
Absci said it will use the proceeds to support ABS-201, its anti-PRLR antibodyfor androgenetic alopecia (pattern hair loss) and endometriosis, as well as working capital and general corporate purposes.

More on Absci

Absci Corporation (ABSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Slideshow
Absci Corporation (ABSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript
Absci Corporation: A Big Binary Approaching In Alopecia
Absci rises after early-stage trial data for hair loss therapy and $100M stock offering
Absci climbs after New Outperform at Leerink on catalyst path

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。